FEDERICO GILBERTO
HAWKINS CARRANZA
Investigador hasta 2019
Pontificia Universidad Católica de Chile
Santiago de Chile, ChilePublicaciones en colaboración con investigadores/as de Pontificia Universidad Católica de Chile (3)
2019
-
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 12, pp. 899-911
2001
-
Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial
Arthritis and Rheumatism, Vol. 44, Núm. 1, pp. 202-211
1998
-
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
New England Journal of Medicine, Vol. 339, Núm. 5, pp. 292-299